Provided by Tiger Trade Technology Pte. Ltd.

Abeona Therapeutics

5.13
-0.0700-1.35%
Volume:376.18K
Turnover:1.93M
Market Cap:278.00M
PE:4.24
High:5.18
Open:5.12
Low:5.07
Close:5.20
52wk High:7.54
52wk Low:3.93
Shares:54.19M
Float Shares:38.26M
Volume Ratio:0.43
T/O Rate:0.98%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.21
EPS(LYR):-1.5527
ROE:75.90%
ROA:-29.57%
PB:1.62
PE(LYR):-3.30

Loading ...

Aug 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Jul 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 18, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 02, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 20, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 15, 2025

Major Issues Report

Form 8-K - Current report